|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.44 CHF | -3.27% |
|
+3.80% | +3.49% |
| 11/03 | Kuros Biosciences AG, 2025 Earnings Call, Mar 10, 2026 | |
| 11/03 | Kuros Biosciences AG Provides Earnings Guidance for the Year 2026-2028 | CI |
| Capitalization | 1.11B 1.43B 1.23B 1.07B 1.94B 132B 2B 13.17B 5.25B 62.97B 5.36B 5.25B 227B | P/E ratio 2025 |
588x | P/E ratio 2026 * | 72.9x |
|---|---|---|---|---|---|
| Enterprise value | 1.09B 1.4B 1.21B 1.04B 1.9B 129B 1.96B 12.91B 5.15B 61.74B 5.25B 5.14B 222B | EV / Sales 2025 |
9.46x | EV / Sales 2026 * | 6.03x |
| Free-Float |
67.49% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Kuros Biosciences AG
| 1 day | -3.27% | ||
| 1 week | +3.80% | ||
| Current month | +5.10% | ||
| 1 month | +15.99% | ||
| 3 months | -5.58% | ||
| 6 months | +20.20% | ||
| Current year | +3.49% |
| 1 week | 25.52 |  | 30.3 |
| 1 month | 24.64 | | 30.3 |
| Current year | 24.2 | | 30.3 |
| 1 year | 14 | | 34.2 |
| 3 years | 1.11 | | 34.2 |
| 5 years | 1.11 | | 34.2 |
| 10 years | 1.11 | | 38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Fair
CEO | Chief Executive Officer | 56 | 12/10/2023 |
Joost de Bruijn
CEO | Chief Executive Officer | 60 | 04/12/2017 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 17/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 14/06/2018 | |
Joost de Bruijn
BRD | Director/Board Member | 60 | 14/06/2018 |
Oliver Walker
BRD | Director/Board Member | 57 | 14/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.27% | +3.80% | +46.15% | +1,758.82% | 1.43B | |
| -1.03% | -1.53% | +20.96% | +95.67% | 44.8B | |
| -1.34% | +0.95% | +50.72% | +15.79% | 40.35B | |
| -3.09% | -6.99% | +89.15% | +675.31% | 30.05B | |
| +8.28% | -12.49% | -7.67% | -28.72% | 21.8B | |
| -2.49% | -0.51% | +49.41% | -29.76% | 19.09B | |
| -1.84% | -2.06% | +27.10% | -28.71% | 16.72B | |
| -2.61% | +9.61% | +56.15% | +181.97% | 13.53B | |
| -1.53% | +4.55% | -13.08% | +979.19% | 12.47B | |
| -4.04% | +5.68% | +66.72% | - | 12.1B | |
| Average | -1.26% | +2.53% | +38.56% | +402.17% | 21.23B | |
| Weighted average by Cap. | -0.91% | +0.09% | +39.39% | +203.38% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 134M 172M 149M 128M 234M 15.87B 241M 1.59B 633M 7.59B 646M 632M 27.34B | 177M 227M 196M 170M 309M 20.97B 318M 2.1B 836M 10.03B 853M 835M 36.12B |
| Net income | 9.2M 11.79M 10.19M 8.8M 16.04M 1.09B 16.49M 109M 43.35M 520M 44.25M 43.32M 1.87B | 18M 23.07M 19.94M 17.21M 31.38M 2.13B 32.26M 213M 84.82M 1.02B 86.58M 84.75M 3.66B |
| Net Debt | -21.77M -27.91M -24.11M -20.82M -37.95M -2.57B -39.02M -257M -103M -1.23B -105M -103M -4.43B | -45.04M -57.74M -49.89M -43.08M -78.52M -5.32B -80.73M -532M -212M -2.55B -217M -212M -9.17B |
Employees
158
Calendar
13/08 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 28.44 CHF | -3.27% | 173,991 |
| 10/03/26 | 29.40 CHF | +10.61% | 815,545 |
| 09/03/26 | 26.58 CHF | +0.76% | 139,655 |
| 06/03/26 | 26.38 CHF | -3.16% | 98,740 |
| 05/03/26 | 27.24 CHF | -0.58% | 116,341 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.44CHF
Average target price
34.65CHF
Spread / Average Target
+21.84%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KURN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition